retatrutide glp-1 gip glucagon receptor agonist Retatrutide—A Game Changer in Obesity Pharmacotherapy Triple GLP-1 / GIP /
Description
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications
In the brain, both GIP and GLP1 are thought to be involved in memory formation as well as the control of appetite
2022;146 doi: 10.1016/j.biopha.2021.112563
Orforglipron side effects Common orforglipron side effects reported in trials are similar to other GLP-1 drugs and mainly affect the digestive system
10.1016/j.molmet.2020.101102 95 NauckM
[DOI] [PubMed] [Google Scholar] 34.Morgan DE, Baron TH, Smith JK, Robbin ML, Kenney PJ
